Oman awarded for eliminating trans-fats from food products
GENEVA: The Sultanate of Oman has been awarded a validation certificate by the World Health Organization (WHO) for eliminating industrially-produced trans-fats from food products.
This milestone reflects the country's strong commitment to improving the quality of life, consolidating preventive healthcare and augmenting public health indicators in line with the strategic objectives of Oman Vision 2040, which aspires to elevate the nation to the ranks of developed countries, with health as a top priority.
The certificate was officially presented on Monday during the 78th World Health Assembly (WHA), currently being held in Geneva, Switzerland, from 19 to 27 May. The Sultanate of Oman's delegation was headed by Dr Hilal bin Ali al Sabti, Minister of Health.
In a press statement, Dr Al Sabti said, 'The elimination of trans-fats constitutes a milestone in our commitment to promote and protect community health. Oman takes pride in being among the nine leading countries globally and the second country in the Arab world to implement this life-saving policy of eliminating this harmful ingredient.' Oman's official delegation will be engaged in WHA78's key issues that address the proposed programme budget for the 2026–2027, as well as the role of the Global Coordination Mechanism on the Prevention and Control of Non-communicable Diseases (NCDs) in supporting WHO's efforts to engage multiple stakeholders in combating NCDs.
The discussions also cover mental health and social connectivity, along with various global strategies and action plans scheduled to be implemented with effect from next year. These include the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition (2021–2025), the Global Strategy for Women's, Children's and Adolescents' Health and the Global Strategic Directions for Nursing and Midwifery (2021–2025).
The Assembly is further addressing the critical issue of antimicrobial resistance. It also is reviewing progress made by the Intergovernmental Negotiating Body responsible for drafting and negotiating a convention, agreement, or other international instrument under the Constitution of the WHO to strengthen pandemic prevention, preparedness and response.
The meeting will cover integrated emergency, critical and surgical care to achieve universal health coverage and protection from health emergencies. It will also address substandard and falsified medical products, as well as global strategies and action plans due to expire within one year, in accordance with the Global Strategy for Digital Health 2020-2025. — ONA
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times of Oman
9 hours ago
- Times of Oman
Royal Hospital emphasises on risk management in the health sector
Muscat: The Royal Hospital on Monday officially launched its Comprehensive Enterprise Risk Management (ERM) programme under the auspices of Dr. Ahmed Salim Al Manthari, Undersecretary of the Ministry of Health for Planning and Health Organization. In his keynote speech, the Undersecretary emphasised the strategic and national importance of risk management in the health sector. He highlighted the impact of implementing comprehensive ERM on governance, transparency, healthcare service quality improvement, and leadership's role in fostering a risk-aware culture and data-driven decision making. He underscored the importance of aligning the risk management program with Oman Vision 2040 and its goals of efficiency, sustainability, and quality of life. He called for genuine commitment in implementing comprehensive ERM through continued training workshops in the coming phase. Dr. Jawaher Mubarak Al Kalbani, Assistant Director General for Medical Support Affairs at the Royal Hospital, stated that launching the ERM programme represents a strategic step toward effective governance, highest quality and safety standards, and modern management. She noted that the programme enhances risk prediction capabilities and supports informed strategic decision-making for institutional sustainability and performance effectiveness. Al Kalbani added that the program is designed based on the American Society for Healthcare Risk Management (ASHRM) model, adapted to national needs. It includes risk classification across eight key domains and development of standardised tools like FMEA and Key Risk Indicators (KRIs). She said that this launch initiates upcoming implementation phases including intensive training courses and building an integrated institutional system for comprehensive, sustainable program application. Engineer Ali Al Sheidani from Oman Vision 2040 Office highlighted the program's alignment with Oman Vision 2040 and future strategies. Dr. Suad Al Ismaili, Director of Quality Management and Patient Safety Department at the Royal Hospital, presented the eight pillars of the comprehensive ERM program and new policy. The ceremony featured a video presentation showcasing the Royal Hospital's ERM journey. Notably, the comprehensive ERM program aims to build an institutional risk-aware culture, enhance response capabilities to various risks (clinical, operational, or strategic), and support risk analysis-based planning for optimal resource utilisation while improving healthcare regulation and patient safety.
Times of Oman
11 hours ago
- Times of Oman
Muscat Municipality organises training programme in pest control
Muscat: In partnership with the World Health Organization (WHO), Muscat Municipality successfully conducted a specialised training programme for the pest control professionals, from 18 May to 1 June 2025. This initiative is part of the Municipality's ongoing efforts to build national expertise in vector control and raise public health standards across the Governorate. Aligned with the latest international standards and best practices, the programme was designed to train the national workforce and field operatives in pest control. It offered a comprehensive approach, combining theoretical knowledge with practical application. It focused on pest identification, risk assessment, and the implementation of integrated, sustainable, and environmentally conscious control strategies. The initiative included a series of scientific lectures and on-site workshops delivered by leading international experts from the WHO. Skilled professionals across the wilayats of Muscat Governorate participated in these sessions, contributing to a dynamic and engaging training environment. 'The collaboration with the WHO underscores Muscat Municipality's commitment to strengthening partnerships with global institutions and capitalising on their expertise across various fields. It enables us to adopt world-class public health practices and further develop the skills and capabilities of our national workforce, contributing directly to national efforts to mitigate health risks and improve quality of life. "We remain steadfast in our investment in human capital, which forms the foundation of the sustainable urban development we aspire to,' said His Excellency Ahmed bin Mohammed Al Humaidi, Chairman of Muscat Municipality. Notably, this programme marks a significant milestone in Muscat Municipality's strategy to establish an effective and enduring pest control system aligned with public health objectives and national priorities. The Municipality also reaffirmed its commitment to enhance cooperation with international organisations, advance knowledge exchange, and launch further specialised training initiatives. Ultimately, this approach will empower national talent and elevate municipal services in line with the highest professional and scientific benchmarks.
Muscat Daily
a day ago
- Muscat Daily
MoH tightens rules on promotion, marketing of drugs in Oman
Muscat – Ministry of Health (MoH) has announced new regulations for advertising and promoting medicines aimed at safeguarding public health and ensuring ethical marketing practices in the pharmaceutical sector. Issued by H E Dr Hilal bin Ali al Sabti, Minister of Health, Ministerial Decision No 135/2025 outlines procedures and conditions that pharmaceutical firms, agents and consultants must follow before promoting any medicinal product in Oman. The decision was issued on May 29 and will come into effect from today. Under the new rules, only licensed pharmaceutical companies, authorised local agents and approved pharmaceutical consulting offices can advertise medicines. All advertising must be pre-approved by the Drug Safety Centre. To be eligible for a licence, the product must be registered, and the advertising content must match the approved drug leaflet and summary of product characteristics. It must clearly define the target audience and avoid any wording that could mislead consumers, exaggerate benefits, harm public health or breach public morals. 'The objective is to protect consumers from misleading information and to ensure that advertisements remain factual and within the ethical boundaries of public health,' a ministry official said. Applicants must submit a copy of the advertisement, the drug's registration certificate, proof of fee payment and any other documents requested by the centre. The Drug Safety Centre is mandated to respond within 60 days. No response within that timeframe implies rejection. If an application is found incomplete, the applicant will be given 30 days to address shortcomings. Failure to do so within that period will result in application cancellation. Licences are valid for three months and may be renewed for similar periods. Renewal requests must be submitted at least 20 days before licence expiry and will be assessed under the same terms. Advertisers must include the licence number in all materials and documentation, use only approved formats and obtain prior approval for any change. Advertising prescription-only medicines is restricted to scientific publications or at conferences and professional meetings attended by pharmacists and healthcare workers.
